Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-05

Clinical Trial Update: Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a zinc, chromium, vitamin C, and copper combination supplement to prevent progression from prediabetes; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chromium (Chromium)
  • Copper (copper)
  • Vitamin C (ascorbic acid)
  • ZINC (Zinc chloride)

Snippet

Sponsor: Indonesia University | Conditions: PreDiabetes, Nutrition | Phase 2 | Status: ACTIVE_NOT_RECRUITING